Improve walking with spinal stimulation
- Trial ID
- NCT06804642
- Official Title
- Rehabilitation of Locomotor Function in Parkinson's Disease by Non-invasive Spinal Cord Stimulation
- Goal
- Improve walking with spinal stimulation
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Louisville
- Study Type
- INTERVENTIONAL
- Enrollment
- 20 participants
- Conditions
- Parkinson Disease
- Interventions
- Spinal cord transcutaneous stimulation (scTS)
Plain-Language Summary
The goal is to improve walking and balance in people with Parkinson's, targeting problems like shuffling, poor coordination, and trouble initiating steps. The approach uses non-invasive spinal cord transcutaneous stimulation, delivering mild electrical pulses through the skin over the lower back to change how spinal networks shape stepping and boost coordination and endurance during gait, often paired with walking practice to reinforce improvements. It is a device-based rehab technique rather than a drug, so it aims to retrain nervous system control of walking. The trial is looking for adults 18 to 80 with Parkinson's who can walk 10 meters and give informed consent, and it excludes people with other major health problems that affect gait, serious cognitive or psychiatric conditions, uncontrolled substance abuse, or anything that would make stimulation unsafe.
Locations
- Frazier Rehab Institute, Louisville, Kentucky, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Spinal cord transcutaneous stimulation (scTS). The goal is to improve walking and balance in people with Parkinson's, targeting problems like shuffling, poor coordination, and trouble initiating steps. The approach uses non-invasive spinal cord transcutaneous stimulation, delivering mild electrical pulses through the skin over the lower back to change how spinal networks shape stepping and boost coordination and endurance during gait, often paired with walking practice to reinforce improvements. It is a device-based rehab technique rather than a drug, so it aims to retrain nervous system control of walking. The trial is looking for adults 18 to 80 with Parkinson's who can walk 10 meters and give informed consent, and it excludes people with other major health problems that affect gait, serious cognitive or psychiatric conditions, uncontrolled substance abuse, or anything that would make stimulation unsafe.
- Who can participate?
- Participants must be between 18 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 5 years.